Nanoparticulate platforms for targeting bone infections: Meeting a major therapeutic challenge

Nanomedicine

Volumn 10, Issue 20, 2015, Pages 3131-3145

  Santos Ferreira, Inês ^a   Bettencourt, Ana ^a   Almeida, António J ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

antibiotics; bone infection; in situ delivery; nanoparticles

Indexed keywords

ANTIBIOTIC AGENT; CALCIUM DERIVATIVE; METAL NANOPARTICLE; NANOCARRIER; NANOPARTICLE; POLYMER; SOLID LIPID NANOPARTICLE; ANTIINFECTIVE AGENT; DELAYED RELEASE FORMULATION; DRUG CARRIER;

ARTICLE; BONE INFECTION; COLLOID; HUMAN; PRIORITY JOURNAL; BONE DISEASES; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; NANOTECHNOLOGY; PROCEDURES;

ANTI-BACTERIAL AGENTS; BONE DISEASES; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY;

EID: 84944255719     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.15.134     Document Type: Article

References (76)

1. Lew DP, Waldvogel FA. Osteomyelitis. Lancet 364, 369-379 (2004).
2. Berendt T, Byren I. Bone and joint infection. Clin. Med. 4(6), 510-518 (2004).
3. Trampuz A, Zimmerli W. Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis. Curr. Infect. Dis. Rep. 10(5), 394-403 (2008).
4. Arciola CR, Campoccia D, Speziale P, Montanaro L, Costerton JW. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials 33(6), 5967-5982 (2012).
5. Harris LG, Richards RG. Staphylococci and implant surfaces: a review. Injury 37(Suppl. 2), S3-S14 (2006).
6. Daghighi S, Sjollema J, van der Mei HC, Busscher HJ, Rochford ETJ. Infection resistance of degradable versus non-degradable biomaterials: an assessment of the potential mechanisms. Biomaterials 34(33), 8013-8017 (2013).
7. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N. Engl. J. Med. 351(16), 1645-1654 (2004).
8. Mannepalli S, Mitchell-Samon L, Guzman N, Relan M, McCarter YS. Mycobacterium tuberculosis osteomyelitis in a patient with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), a case report. Cases J. 3, 67 (2010).
9. Lee J, Kang CI, Lee JH et al. Risk factors for treatment failure in patients with prosthetic joint infections. J. Hosp. Infect. 75, 273-276 (2010).
10. Trampuz A, Zimmerli W. Diagnosis and treatment of infections associated with fracture-fixation devices. Injury 37(Suppl.2), S59-S66 (2006).
11. Hby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents 35, 322-332 (2010).
12. Ginebra MP, Canal C, Espanol M, Pastorino D, Montufar EB. Calcium phosphate cements as drug delivery materials. Adv. Drug Deliv. Rev. 64(12), 1090-1110 (2012).
13. Campoccia D, Montanaro L, Speziale P, Arciola CR. Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. Biomaterials 31(25), 6363-6377 (2010).
14. Couvreur P. Nanoparticles in drug delivery: past, present and future. Adv. Drug Deliv. Rev. 65(1), 21-23 (2013).
15. Vert M. Polymeric biomaterials: strategies of the past vs. strategies of the future. Prog. Polym. Sci. 32, 755-761 (2007).
16. Uskokovic V, Desai TA. Nanoparticulate drug delivery platforms for advancing bone infection therapies. Expert Opin. Drug Deliv. 11(12), 1899-1912 (2014).
17. European Council. Directive 2007/47/EC. http://eur-lex.europa.eu/legalcontent
18. Pardeike J, Hommoss A, Mler RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm. 366(1-2), 170-184 (2009).
19. Liu XM, Zhang Y, Chen F et al. Prevention of orthopedic device-associated osteomyelitis using oxacillin-containing biomineral-binding liposomes. Pharm. Res. 29, 3169-3179 (2012).
20. Ma T, Shang BC, Tang H et al. Nano-hydroxyapatite/chitosan/konjac glucomannan scaffolds loaded with cationic liposomal vancomycin: preparation, in vitro release and activity against Staphylococcus aureus biofilms. J. Biomater. Sci. Polym. Ed. 22(12), 1669-1681 (2011).
21. Zhu CT, Xu YQ, Shi J, Li J, Ding J. Liposome combined porous beta-TCP scaffold: preparation, characterization, and anti-biofilm activity. Drug Deliv. 17(6), 391-398 (2010).
22. Zhou TH, Su M, Shang BC et al. Nano-hydroxyapatite/-tricalcium phosphate ceramics scaffolds loaded with cationic liposomal ceftazidime-preparation, release characteristics in vitro and inhibition to Staphylococcus aureus biofilms. Drug Dev. Ind. Pharm. 38(11), 1298-304 (2012).
23. Moghadas-Sharif N, Fazly Bazzaz BS, Khameneh B, Malaekeh-Nikouei B. The effect of nanoliposomal formulations on Staphylococcus epidermidis biofilm. Drug Dev. Ind. Pharm. 41(3), 445-450 (2015).
24. Kadry AA, Al-Suwayeh SA, Abd-Allah ARA, Bayomi MA. Treatment of experimental osteomyelitis by liposomal antibiotics. J. Antimicrob. Chemother. 54, 1103-1108 (2004).
25. Hui T, Yongqing X, Tiane Z et al. Treatment of osteomyelitis by liposomal gentamicin-impregnated calcium sulphate. Arch. Orthop. Trauma Surg. 129, 1301-1308 (2009).
26. Sande L, Sanchez M, Montes J et al. Liposomal encapsulation of vancomycin improves killing of methicillinresistant Staphylococcus aureus in a murine infection model. J. Antimicrob. Chemother. 67(9), 2191-2194 (2012).
27. Onyeji CO, Nightingale CH, Marangos MN. Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin. Infection 22(5), 338-342 (1994).
28. Chakraborty SP, Sahu SK, Pramanik P, Roy S. In vitro antimicrobial activity of nanoconjugated vancomycin against drug resistant Staphylococcus aureus. Int. J. Pharm. 436(1-2), 659-676 (2012).
29. Shi Z, Neoh KG, Kang ET, Wang W. Antibacterial and mechanical properties of bone cement impregnated with chitosan nanoparticles. Biomaterials 27(11), 2440-2449 (2006).
30. Mohammadi G, Nokodchi A, Barzegar-Jalali M et al. Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system. Colloids Surf. B Biointerfaces 88(1), 39-44 (2011).
31. Toti US, Guru BR, Hali M et al. Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles. Biomaterials 32(27), 6606-6613 (2011).
32. Ferreira IS, Bettencourt A, Brisey B et al. Improvement of the antibacterial activity of daptomycin-loaded polymeric microparticles by Eudragit RL 100: an assessment by isothermal microcalorimetry. Int. J. Pharm. 485(1-2), 171-182 (2015).
33. Turos E, Reddy GSK, Greenhalgh K et al. Penicillinbound polyacrylate nanoparticles: restoring the activity of beta-lactam antibiotics against MRSA. Bioorg. Med. Chem. Lett. 17(12), 3468-3472 (2007).
34. Xu Q, Czernuszka JT. Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres. J. Control. Release 127(2), 146-153 (2008).
35. Reddy NS, Sowmya S, Bumgardner JD, Chennazhi KP, Biswas R, Jayakumar R. Tetracycline nanoparticles loaded calcium sulfate composite beads for periodontal management. Biochim. Biophys. Acta 1840, 2080-2090 (2014).
36. University College Cardiff Consultants Ltd: WO2015004450A1 (2015).
37. Loca D, Sokolova M, Locs J, Smirnova A, Irbe Z. Calcium phosphate bone cements for local vancomycin delivery. Mater. Sci. Eng. C 49, 106-113 (2015).
38. Lian X, Liu H, Wang X, Xu S, Cui F, Bai X. Antibacterial and biocompatible properties of vancomycin-loaded nanohydroxyapatite-collagen-poly (lactic acid) bone substitute. Prog. Nat. Sci. 23(6), 549-556 (2013).
39. Uskokovi V, Hoover C, Vukomanovi M, Uskokovi DP, Desai TA. Osteogenic and antimicrobial nanoparticulate calcium phosphate and poly-(D,L-lactide-co-glycolide) powders for the treatment of osteomyelitis. Mater. Sci. Eng. C Mater. Biol. Appl. 33, 3362-3373 (2013).
40. Uskokovi V, Desai TA. Simultaneous bactericidal and osteogenic effect of nanoparticulate calcium phosphate powders loaded with clindamycin on osteoblasts infected with Staphylococcus aureus. Mat. Sci. Eng. C 37(1), 210-222 (2014).
41. Rauschmann MA, Wichelhaus TA, Stirnal V et al. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials 26(15), 2677-2684 (2005).
42. Ferraz MP, Mateus AY, Sousa JC, Monteiro FJ. Nanohydroxyapatite microspheres as delivery system for antibiotics: release kinetics, antimicrobial activity, and interaction with osteoblasts. J. Biomed. Mater. Res. A 81(4), 994-1004 (2007).
43. Yingguang L, Zhuoru Y, Jiang C. Preparation, characterization and antibacterial property of cerium substituted hydroxyapatite nanoparticles. J. Rare Earths 25(4), 452-456 (2007).
44. Ravi ND, Balu R, Sampath Kumar TS. Strontiumsubstituted calcium deficient hydroxyapatite nanoparticles: synthesis, characterization, and antibacterial properties. J. Am. Ceram. Soc. 95, 2700-2708 (2012).
45. Gopi P, Ramya S, Rajeswari D, Karthikeyan P, Kavitha L. Strontium, cerium co-substituted hydroxyapatite nanoparticles: synthesis, characterization, antibacterial activity towards prokaryotic strains and in vitro studies. Colloids Surf. A Physicochem. Eng. Asp. 451, 172-180 (2014).
46. Tank KP, Chudasama KS, Thaker VS, Joshi MJ. Cobaltdoped nanohydroxyapatite: synthesis, characterization, antimicrobial and hemolytic studies. J. Nanopart. Res. 15, 1644 (2013).
47. Dz M, Barba F, Miranda M, Guitia F, Torrecillas R, Moya JS. Synthesis and antimicrobial activity of a silver-hydroxyapatite nanocomposite. J. Nanomater. doi:10.1155/2009/498505 (2009) (Epub ahead of print).
48. Neut D, van de Belt H, van Horn JR, van der Mei HC, Busscher HJ. Residual gentamicin-release from antibioticloaded polymethylmethacrylate beads after 5 years of implantation. Biomaterials 24(10), 1829-1831 (2003).
49. Zhong Z, Jinli Qin J, Ma J. Cellulose acetate/hydroxyapatite/chitosan coatings for improved corrosion resistance and bioactivity. Mater. Sci. Eng. C Mater. Biol. Appl. 49, 251-255 (2015).
50. Angrisani N, Foth F, Kietzmann M et al. Increased accumulation of magnetic nanoparticles by magnetizable implant materials for the treatment of implant-associated complications. J. Nanobiotechnol. 11, 34 (2013).
51. Pareta RA, Taylor E, J Webster TJ. Increased osteoblast density in the presence of novel calcium phosphate coated magnetic nanoparticles. Nanotechnology 19(26), 265101 (2008).
52. Alt V, Bechert T, Steinrucke P et al. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 25, 4383-4391 (2004).
53. Slane J, Vivanco J, Rose W, Ploeg HL, Matthew Squire M. Mechanical, material, and antimicrobial properties of acrylic bone cement impregnated with silver nanoparticles. Mater. Sci. Eng. C Mater. Biol. Appl. 48, 188-196 (2015).
54. Prokopovich P, Leech R, Carmalt CJ, Parkin IP, Perni S. A novel bone cement impregnated with silver-tiopronin nanoparticles: its antimicrobial, cytotoxic, and mechanical properties. Int. J. Nanomedicine 8, 2227-2237 (2013).
55. Prokopovich P, Kobrick M, Brousseau E, Perni S. Potent antimicrobial activity of bone cement encapsulating silver nanoparticles capped with oleic acid. J. Biomed. Mater. Res. B Appl. Biomater. 103B, 273-281 (2015).
56. Gonzez-Schez MI, Perni S, Tommasi G et al. Silver nanoparticle based antibacterial methacrylate hydrogels potential for bone graft applications. Mater. Sci. Eng. C Mater. Biol. Appl. 50, 332-340 (2015).
57. Miranda M, Fernandez A, Lopez-Esteban S, Malpartida F, Moya JS, Torrecillas R. Ceramic/metal biocidal nanocomposites for bone-related applications. J. Mater. Sci. Mater. Med. 23, 1655-1662 (2012).
58. Marsich E, Bellomo F, Turco G, Travan A, Donati I, Paoletti S. Nano-composite scaffolds for bone tissue engineering containing silver nanoparticles: preparation, characterization and biological properties. J. Mater. Sci. Mater. Med. 24(7), 1799-1807 (2013).
59. Suvannapruk W, Thammarakcharoen F, Phanpiriya P, Suwanprateeb J. Development of antibiotics impregnated nanosized silver phosphate-doped hydroxyapatite bone graft. J. Nanomater. 2013, 11-9 (2013).
60. Secinti KD, zalp H, Attar A, Sargon MF. Nanoparticle silver ion coatings inhibit biofilm formation on titanium implants. J. Clin. Neurosci. 18, 391-395 (2011).
61. Elizabeth E, Baranwal G, Krishnan AG, Menon D, Nair M. ZnO nanoparticle incorporated nanostructured metallic titanium for increased mesenchymal stem cell response and antibacterial activity. Nanotechnology 25(11), 115101 (2014).
62. Xie CM, Lu X, Wang KF et al. Silver nanoparticles and growth factors incorporated hydroxyapatite coatings on metallic implant surfaces for enhancement of osteoinductivity and antibacterial properties. ACS Appl. Mater. Interfaces 6(11), 8580-8589 (2014).
63. Tsuang YH, Sun JS, Huang YC, Lu CH, Chang WH, Wang CC. Studies of photokilling of bacteria using titanium dioxide nanoparticles. Artif. Organs 32(2), 167-174 (2008).
64. Angrisani N, Foth F, Kietzmann M et al. Increased accumulation of magnetic nanoparticles by magnetizable implant materials for the treatment of implant-associated complications. J. Nanotech. 11, 34 (2013).
65. Wei L, Lu J, Xu H, Patel A, Chen ZS, Chen G. Silver nanoparticles: synthesis, properties, and therapeutic applications. Drug Discov. Today 20(5), 595-601 (2015).
66. Gallo J, Holinka M, Moucha CS. Antibacterial surface treatment for orthopaedic implants. Int. J. Mol. Sci. 15, 13849-13880 (2014).
67. Albers CE, Hofstetter W, Siebenrock KA, Landmann R, Klenke FM. In vitro cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations. Nanotoxicology 7(3), 30-36 (2011).
68. Mouzopoulos G, Kanakaris NK, Kontakis G et al. Management of bone infections in adults: the surgeon's and microbiologist's perspectives. Injury 42, S18-S23 (2011).
69. Forier K, Raemdonck K, De Smedt SC et al. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms. J. Control. Release 190, 607-623 (2014).
70. Hby N, Bjarnsholt T, Moser C et al. ESCMID guideline for the diagnosis and treatment of biofilm infections. Clin. Microbiol. Infect. 21(Suppl. 1), S1-S25 (2014).
71. Wu W, Wang W, Li J. Star polymers: advances in biomedical applications. Prog. Pol. Sci. 46, 55-85 (2015).
72. Ganewatta MS, Tang C. Controlling macromolecular structures towards effective antimicrobial polymers. Polymer 63, A1-A29 (2015).
73. Trajkovski B, Petersen A, Strube P, Mehta M, Duda GN. Intra-operatively customized implant coating strategies for local and controlled drug delivery to bone. Adv. Drug Deliv. Rev. 64, 1142-1151 (2012).
74. WitsE. The limits of the local antibiotic therapy. In: Infection and Local Treatment in Orthopedic Surgery. Meani E, Romano C, Crosby L, Hofmann G, Calonego G. (Eds). Springer-Verlag, Berlin, Germany, 67-72 (2007).
75. Ehmann F, Sakai-Kato K, Duncan R et al. Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines. Nanomedicine (Lond.) 8(5), 849-856 (2013).
76. European Medicines Agency. Reflection paper on nanotechnology-based medicinal products for human use. www.ema.europa.eu/docs/en-GB/document-library